1. Home
  2. EYPT vs INOD Comparison

EYPT vs INOD Comparison

Compare EYPT & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$12.86

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$45.01

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
INOD
Founded
1987
1988
Country
United States
United States
Employees
N/A
3000
Industry
Biotechnology: Laboratory Analytical Instruments
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
EYPT
INOD
Price
$12.86
$45.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$31.80
$100.00
AVG Volume (30 Days)
1.2M
804.7K
Earning Date
03-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.37
EPS
N/A
0.92
Revenue
$7,539,000.00
$86,775,000.00
Revenue This Year
N/A
$35.60
Revenue Next Year
$1,031.72
$29.67
P/E Ratio
N/A
$47.34
Revenue Growth
N/A
9.84
52 Week Low
$3.91
$26.70
52 Week High
$19.11
$93.82

Technical Indicators

Market Signals
Indicator
EYPT
INOD
Relative Strength Index (RSI) 36.53 47.84
Support Level $12.05 $44.25
Resistance Level $13.32 $52.34
Average True Range (ATR) 1.01 2.01
MACD -0.33 0.42
Stochastic Oscillator 3.45 60.41

Price Performance

Historical Comparison
EYPT
INOD

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Share on Social Networks: